In an article published in the journal Nature on September 26, 2018 ("Immunotherapy Offers a Promising Bet Against Brain Cancer,") Duke Neurosurgery Chair John H. Sampson, MD, PhD, provides commentary on the promise of the therapy to treat glioblastoma, the deadliest form of brain cancer.